Kathy Yi, SVP & Chief Financial Officer at SANGAMO THERAPEUTICS, INC (SGMO), sold 5,000 shares at $14.77 ($74K) on 2018-07-16, disclosed to the SEC on 2018-07-17.
Open-market sale of $74k SGMO by SVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SGMO | SELL | 2019-03-18 | $50K | — | Filing → |
| SGMO | SELL | 2019-03-05 | $50K | — | Filing → |
| SGMO | SELL | 2019-01-16 | $110K | — | Filing → |